Skip to content
lifestyle.tweeternet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CURIS, INC.
Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026
November 5, 2026
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors
October 16, 2026
Curis, Inc. Announces Pricing of $5.6 Million Public Offering
August 13, 2026
Curis Doses First Five Patients in TakeAim CLL Study
July 30, 2026
Curis Announces Positive Emavusertib Update
July 22, 2026
Curis Consents First Six Patients in TakeAim CLL Study
July 6, 2026
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
June 26, 2026
Curis Provides First Quarter 2026 Business Update
May 12, 2026